Stephen C. Mack

18.8k total citations · 3 hit papers
71 papers, 5.2k citations indexed

About

Stephen C. Mack is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Stephen C. Mack has authored 71 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Genetics and 18 papers in Cancer Research. Recurrent topics in Stephen C. Mack's work include Glioma Diagnosis and Treatment (31 papers), Epigenetics and DNA Methylation (12 papers) and Chromatin Remodeling and Cancer (9 papers). Stephen C. Mack is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Epigenetics and DNA Methylation (12 papers) and Chromatin Remodeling and Cancer (9 papers). Stephen C. Mack collaborates with scholars based in United States, Canada and Germany. Stephen C. Mack's co-authors include Jeremy N. Rich, Claudia L.L. Valentim, Justin D. Lathia, Erin E. Mulkearns-Hubert, Michael D. Taylor, Qiulian Wu, Paul A. Northcott, Stefan M. Pfister, Christopher G. Hubert and Briana C. Prager and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Stephen C. Mack

67 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer stem cells in glioblastoma

2015 1.2k citations Justin D. Lathia, Stephen C. Mack et al. Genes & Development profile →
Medulloblastoma Comprises Four Distinct Molecular Variants

2010 886 citations Paul A. Northcott, Andrey Korshunov et al. Journal of Clinical Oncology profile →
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo

2016 462 citations Christopher G. Hubert, Maricruz Rivera et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen C. Mack United States	28	3.1k	1.9k	1.4k	1.1k	443	71	5.2k
Kyeung Min Joo South Korea	37	2.9k 0.9×	1.3k 0.7×	1.4k 1.0×	1.6k 1.4×	281 0.6×	135	5.3k
Angela Gritti Italy	35	4.8k 1.5×	2.3k 1.2×	1.2k 0.8×	1.7k 1.5×	461 1.0×	81	8.7k
Sieger Leenstra Netherlands	37	1.9k 0.6×	1.9k 1.0×	902 0.6×	1.1k 1.0×	330 0.7×	112	5.1k
Renée M. McKay United States	25	2.5k 0.8×	850 0.4×	969 0.7×	1.2k 1.0×	227 0.5×	47	4.4k
Christoph P. Beier Denmark	30	1.6k 0.5×	1.3k 0.7×	1.0k 0.7×	1.4k 1.3×	313 0.7×	82	3.9k
Svetlana Kotliarova United States	21	2.2k 0.7×	1.2k 0.6×	880 0.6×	1.2k 1.0×	260 0.6×	26	3.6k
Harley I. Kornblum United States	59	6.7k 2.2×	2.1k 1.1×	2.0k 1.4×	2.1k 1.9×	486 1.1×	158	11.7k
Hugo Guerrero‐Cazares United States	36	1.8k 0.6×	1.1k 0.6×	704 0.5×	554 0.5×	591 1.3×	90	3.6k
Steven M. Pollard United Kingdom	40	4.3k 1.4×	1.2k 0.6×	988 0.7×	860 0.8×	508 1.1×	99	5.9k
Robert J. Wechsler‐Reya United States	38	5.0k 1.6×	1.5k 0.8×	948 0.7×	1.4k 1.2×	137 0.3×	105	6.5k

Countries citing papers authored by Stephen C. Mack

Since Specialization

Citations

This map shows the geographic impact of Stephen C. Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Mack more than expected).

Fields of papers citing papers by Stephen C. Mack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Mack. The network helps show where Stephen C. Mack may publish in the future.

Co-authorship network of co-authors of Stephen C. Mack

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Mack. A scholar is included among the top collaborators of Stephen C. Mack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Mack. Stephen C. Mack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Czaplinski, Jeffrey T., Suzanne J. Forrest, Neerav Shukla, et al.. (2024). TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS10077–TPS10077.

Li, Fanying, Kailin Yang, Xinya Gao, et al.. (2024). A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice. Science Translational Medicine. 16(767). eadk9524–eadk9524. 5 indexed citations

Chen, Hsiao‐Chi, Malcolm F. McDonald, Michael R. Williamson, et al.. (2024). Histone serotonylation regulates ependymoma tumorigenesis. Nature. 632(8026). 903–910. 21 indexed citations

Houke, Haley, et al.. (2023). EPEN-04. DEVELOPMENT OF B7-H3-TARGETED CAR T CELL THERAPY FOR EPENDYMOMA. Neuro-Oncology. 25(Supplement_1). i27–i27.

Reuther, Jacquelyn, Kelsey C. Bertrand, Raghu Chandramohan, et al.. (2021). Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling. JCO Precision Oncology. 5(5). 1221–1227. 4 indexed citations

Jane, Esther P., Daniel R. Premkumar, Brian Golbourn, et al.. (2020). Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. Molecular Cancer Research. 18(7). 1004–1017. 13 indexed citations

Dong, Zhen, Guoxin Zhang, Meng Qu, et al.. (2019). Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Cancer Discovery. 9(11). 1556–1573. 217 indexed citations

Ryall, Scott, Miguel A. Guzmán, Samer K. Elbabaa, et al.. (2017). H3 K27M mutations are extremely rare in posterior fossa group A ependymoma. Child s Nervous System. 33(7). 1047–1051. 36 indexed citations

Jin, Xun, Leo J.Y. Kim, Qiulian Wu, et al.. (2017). Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nature Medicine. 23(11). 1352–1361. 258 indexed citations

10.

Mack, Stephen C., Hiromichi Suzuki, & Michael D. Taylor. (2017). Transposase-driven rearrangements in human tumors. Nature Genetics. 49(7). 975–977. 1 indexed citations

11.

Hubert, Christopher G., Maricruz Rivera, Lisa C. Spangler, et al.. (2016). A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. Cancer Research. 76(8). 2465–2477. 462 indexed citations breakdown →

12.

Fang, Xiaoguang, Wenchao Zhou, Qiulian Wu, et al.. (2016). Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. The Journal of Experimental Medicine. 214(1). 245–267. 127 indexed citations

13.

Lathia, Justin D., Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim, & Jeremy N. Rich. (2015). Cancer stem cells in glioblastoma. Genes & Development. 29(12). 1203–1217. 1182 indexed citations breakdown →

14.

Mack, Stephen C., Christopher G. Hubert, Tyler E. Miller, Michael D. Taylor, & Jeremy N. Rich. (2015). An epigenetic gateway to brain tumor cell identity. Nature Neuroscience. 19(1). 10–19. 71 indexed citations

15.

Davenport, Richard, Johannes Grosse, Kazumasa Ogawa, et al.. (2014). Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing. European Journal of Pharmacology. 727. 1–7. 46 indexed citations

16.

Mack, Stephen C., et al.. (2013). Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma. Oncogene. 33(20). 2674–2680. 19 indexed citations

17.

Dubuc, Adrian M., Stephen C. Mack, Alexander Unterberger, Paul A. Northcott, & Michael D. Taylor. (2012). The Epigenetics of Brain Tumors. Methods in molecular biology. 863. 139–153. 33 indexed citations

18.

Northcott, Paul A., Thomas Hielscher, Adrian M. Dubuc, et al.. (2011). Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathologica. 122(2). 231–240. 155 indexed citations

19.

Mack, Stephen C. & Miguel P. Eckstein. (2011). Object co-occurrence serves as a contextual cue to guide and facilitate visual search in a natural viewing environment. Journal of Vision. 11(9). 9–9. 140 indexed citations

20.

Northcott, Paul A., Andrey Korshunov, Hendrik Witt, et al.. (2010). Medulloblastoma Comprises Four Distinct Molecular Variants. Journal of Clinical Oncology. 29(11). 1408–1414. 886 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact